SCHEMBL3493473

SCHEMBL3493473

COCCOC(=O)Nc1ccc(C=O)s1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 1/20 0.43
CSNK2A1 P68400 1/20 0.43
TSHR P16473 2/20 0.37
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
GAA P10253 2/20 0.35
PKM P14618 1/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
ALDH1A1 P00352 3/20 0.34
RECQL P46063 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3494992 0.78 HPGD (0.44) CSNK2A2CSNK2A1TSHRLMNATP53
SCHEMBL3492711 0.73 CSNK2A2 (0.38) CSNK2A2CSNK2A1TSHRLMNATP53
SCHEMBL1433832 0.73 HSD17B10 (0.67) TSHRTP53GAAPKMALOX15
SCHEMBL25917537 0.69 SMN1; SMN2 (0.50) CSNK2A2CSNK2A1TSHRLMNATP53
SCHEMBL27101167 0.68 SAE1 (0.49) CSNK2A2CSNK2A1TSHRLMNATP53
SCHEMBL3492000 0.68 HPGD (0.50) TSHRLMNANPSR1GAAALOX15
SCHEMBL11119637 0.68 SAE1 (0.49) CSNK2A2CSNK2A1TSHRLMNATP53
SCHEMBL2281889 0.68 HPGD (0.50) TSHRLMNATP53NPSR1HSD17B10
SCHEMBL5623097 0.67 NPC1 (0.68) TSHRLMNATP53NPSR1GAA
SCHEMBL13073361 0.67 RAB9A (0.56) LMNATP53NPSR1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100081652-A1 Cinnamoyl Compound and Use Thereof SHIRAKI HIROAKI 2010-04-01 US disclosed
US-20100081652-A1 Cinnamoyl Compound and Use Thereof SHIRAKI HIROAKI 2010-04-01 US disclosed
US-20100081652-A1 Cinnamoyl Compound and Use Thereof SHIRAKI HIROAKI 2010-04-01 US disclosed
EP-1857455-A1 CINNAMOYL COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2007-11-21 EP disclosed
EP-1857455-A1 CINNAMOYL COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2007-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081652-A1 Cinnamoyl Compound and Use Thereof COL2A1, MMP7, COL14A1 CSNK2A2 1993/4885CSNK2A1 2060/4885TSHR 4872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.